Alan Swann, MRCPsych. | Psychiatrist.com

Original Research

A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome

January 1, 2004

Clive G. Ballard, Alan Thomas, Jane Fossey, et al